lpr /J (MRL/lpr) mice represent a well-established mouse model of human systemic lupus erythematosus. MRL/lpr mice homozygous for the spontaneous lymphoproliferation mutation (lpr) are characterized by systemic autoimmunity, massive lymphadenopathy associated with proliferation of aberrant T cells, splenomegaly, hypergammaglobulinemia, arthritis, and fatal immune complex-mediated glomerulonephritis. It was reported previously that steady-state mRNA levels for the chemokine (C-C motif) receptor 2 (Ccr2) continuously increase in kidneys of MRL/lpr mice. For examining the role of Ccr2 for development and progression of immune complex-mediated glomerulonephritis, Ccr2-deficient mice were generated and backcrossed onto the MRL/lpr genetic background. Ccr2-deficient MRL/lpr mice developed less lymphadenopathy, had less proteinuria, had reduced lesion scores, and had less infiltration by T cells and macrophages in the glomerular and tubulointerstitial compartment. Ccr2-deficient MRL/lpr mice survived significantly longer than MRL/lpr wild-type mice despite similar levels of circulating immunoglobulins and comparable immune complex depositions in the glomeruli of both groups. Anti-dsDNA antibody levels, however, were reduced in the absence of Ccr2. The frequency of CD8 ؉ T cells in peripheral blood was significantly lower in Ccr2-deficient MRL/lpr mice. Thus Ccr2 deficiency influenced not only monocyte/ macrophage and T cell infiltration in the kidney but also the systemic T cell response in MRL/lpr mice. These data suggest an important role for Ccr2 both in the general development of autoimmunity and in the renal involvement of the lupus-like disease. These results identify Ccr2 as an additional possible target for the treatment of lupus nephritis.
S ystemic lupus erythematosus is an autoimmune disease with immune complex-mediated glomerulonephritis as a major manifestation and determinant of the disease outcome (1) . The MRL/lpr mouse carries a mutation in the apoptosis-related Fas gene, resulting in autoreactive lymphocyte proliferation, and is considered as a mouse model that closely mimics the human disease with lymphadenopathy; splenomegaly; hypergammaglobulinemia with anti-dsDNA antibodies that lead to tissue deposition; and injury in various organs, including lung and kidney (2, 3) . These pathophysiologic processes are mediated by immune complex deposition, complement activation, and infiltration of inflammatory leukocytes (4, 5) . The renal leukocyte infiltrates consist mostly of macrophages and T lymphocytes. These cells are major contributors to the development of progressive renal insufficiency, ultimately resulting in the death of the MRL/lpr mice.
Numerous studies in both human and experimental murine lupus have provided evidence that chemokines play a considerable role during the development and progression of the renal disease. We and others have proposed that deposition of immune complexes and complement activation leads to local generation of chemokines in the kidney followed by the influx of macrophages and T cells (6) . Initially, this may be restricted to the glomerulus with subsequent expansion to the tubulointerstitial compartment and development of progressive renal insufficiency (7) . This hypothesis is supported by studies with MRL/lpr mice carrying a targeted deletion of the Ccl2 (murine MCP-1) gene (5) or treated with antagonists for Ccl2 (8, 9) . In both cases, an attenuation of the nephritis has been observed. Furthermore, Ccl2-deficient MRL/ lpr mice showed a marked reduction of inflammatory lesions, including in the kidney, leading to prolonged survival (5) . The chemokine receptor Ccr2, which represents the only known receptor for Ccl2, is considered to play a role not only in the local infiltration of macrophages and T cells but also in the development and bias of the overall immune response (10) . Surprisingly, Ccr2 and Ccl2 have opposite effects on Th1 versus Th2 polarization. Ccr2-deficient mice show decreased IFN-␥ secretion, i.e., a Th1 defect (11) , whereas Ccl2-deficient mice show predominantly a defect of Th2 cytokine secretion (12) . Possibly because of these differences, conflicting results have been obtained with Ccl2-and Ccr2-deficient mice in several disease models (13) . These may relate in part to the fact that in addition to Ccl2, other Ccr2 ligands exist (Ccl7/MCP-3, Ccl8/MCP-2, and Ccl12/MCP-5) (13) and that other, yet unidentified, receptor(s) for Ccl2 may exist (14) .
Although Ccr2-deficient mice have been studied in many disease models (15) , data about the role of Ccr2 in lupus nephritis are still missing. This report describes the generation and analysis of Ccr2-deficient MRL/lpr mice with a main focus on the development and progression of lupus nephritis.
Materials and Methods

Animals
MRL/MpJ-Fas lpr /J (briefly MRL/lpr) mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and subsequently maintained as a breeding colony in our animal facility. All mice were housed under specific pathogen free conditions. All animal experiments were performed in compliance with current guidelines and approved by local authorities.
Generation of Ccr2-Deficient MRL/lpr Mice
A targeting vector ( Figure 1A ) was constructed and electroporated into E14 -1 embryonic stem (ES) cells. A total of 192 ES cell clones that were resistant to G418 and Ganciclovir were screened by Southern blot analysis ( Figure 1B ). Homologous recombination within the 3Ј-homology arm was confirmed by long-range PCR (Expand Long Template PCR System; Roche Applied Science (Penzburg, Germany), forward primer 5Ј-CAGAAGAACGGCATCAAGGTGAAC-3Ј, reverse primer 5Ј-TGTGGAACAAACTTTATGCTGGGG-3Ј; Figure 1C ). Two positive ES cell clones were microinjected into C57BL/6 blastocysts. Resulting chimeras were mated with C57BL/6 wild-type (wt) mice for germline transmission. A more detailed description is available upon request. The resulting heterozygous Ccr2-deficient mice were backcrossed for seven generations onto the MRL/lpr background and then intercrossed to obtain Ccr2 Ϫ/Ϫ MRL/lpr mice that were used for all experiments.
For survival analysis, four additional Ccr2-deficient mice that were backcrossed for 10 generations were included. All experiments were performed with virgin female mice homozygous for the lpr mutation.
Genotype Analysis
All mice were genotyped by PCR using genomic DNA that was isolated from tail snips and the following primers: Ccr2 forward 5Ј-AAAGGAAATGGAAGACAATAATATG-3Ј; Ccr2 reverse 5Ј-AAAG-GCAAACTGTCACTTACTTTAC-3Ј; EGFP reverse 5Ј-GTCAGGGTG-GTCACGAGG-3Ј; Fas forward 5Ј-AAAGGTTACAAAAGGTCACCC-3Ј; Fas reverse 5Ј-GGTGCAGCCAGAAGCTAG-3Ј; lpr reverse 5Ј-GTTCCTCTTAGCATCTCTCTGC-3Ј.
Collection of Blood, Urine, and Tissue Samples and Determinations of Blood Urea Nitrogen, Creatinine, and Urinary Albumin
Blood and spot urine samples were obtained and determinations were performed as described previously (6, 16) . After a final bleeding step, anesthetized mice were killed by cervical dislocation. One kidney was snap-frozen in liquid nitrogen and used exclusively for isolation of total RNA. The other kidney was used for histologic and immunohistologic analyses.
Histopathology
A renal pathologist performed in a blinded manner the histopathologic analysis as described previously (17) . Glomerular lesions were graded semiquantitatively from 0 to 3ϩ for hypercellularity, mesangial matrix expansion, and necrosis (0, absence; 1, mild; 2, moderate; 3, severe), as well as for the percentage of sclerotic glomeruli and presence of crescents (0, Ͻ10%; 1, 10 to 25%; 2, 25 to 40%; 3, Ͼ40%). Tubulointerstitial lesions were also graded from 0 to 3ϩ for peritubular and pericapillary mononuclear cell infiltrate, tubular damage, interstitial fibrosis, and vasculitis. Finally, perivascular lymphoproliferative mononuclear cell infiltrate was graded from 0 (absence) to 3ϩ (maximal intensity). Global glomerular and tubulointerstitial lesion scores were calculated for each mouse from the sum of all parameters.
Immunofluorescence and Immunohistochemistry
Direct immunofluorescence was performed on 5-m ether/ethanolfixed cryostat sections using FITC-conjugated rabbit anti-mouse IgG and goat anti-mouse complement C3 antibodies (16) . CD3-, ER-HR3-, Mac-2-, and Ki-67-positive cells were detected using 4-m-thick paraffin sections from renal tissue (17, 18) . IgG of the corresponding isotype served as negative control. For quantification, positively stained cells were counted either within 20 glomeruli or within 10 high-power fields (ϫ630) of tubulointerstitial tissue and expressed as cells per glomerular cross-section or high-power field.
RNase Protection Assay
Cytokine, chemokine, and chemokine receptor mRNA expression was analyzed in kidney RNA from wt and Ccr2 Ϫ/Ϫ MRL/lpr mice using RPA template sets mCK-3, mCK-5b, and mCR-5 (BD Biosciences, Heidelberg, Germany) (19) . Integrity of RNA samples was confirmed by agarose gel electrophoresis. For chemokine receptors, 30 g/lane total kidney RNA was used; for cytokines and chemokines, 10 g/lane was used. Bands were quantified by phosphorimaging (Storm 840 PhosphorImager; Molecular Dynamics, Sunnyvale, CA) using ImageQuant software.
Real-Time Reverse Transcriptase-PCR
Spleen IFN-␥ mRNA levels were quantified by real-time RT-PCR as described (20) using a predesigned probe and primer set from Applied Biosystems (Darmstadt, Germany). The normalized expression values were multiplied by a factor of 10 5 .
Analysis of Peripheral Blood by Flow Cytometry and ELISA
Blood was collected from the retro-orbital plexus of anesthetized mice and peripheral blood leukocytes were stained after erythrocyte lysis with antibodies against CD3 (clone 17A2), CD4 (clone RM4 -5), CD8␤ (clone H35-17.2), CD19 (clone 1D3), CD49b (clone DX5), B220 (clone RA3-6B2), and Gr-1 (clone RB6 -8C5; all PharMingen, Heidelberg, Germany). Samples were acquired (25,000 leukocytes) using a high-throughput sampler on a FACS Calibur (BD Biosciences, San Jose, CA) and analyzed using FlowJo software (Tree Star, Ashland, OR).
Plasma levels of Ig isotypes were determined by standard sandwich ELISA using goat anti-mouse Ig antibodies and alkaline phosphatase (AP) conjugates (SouthernBiotech, Birmingham, AL). Antibodies against double-stranded DNA were detected by indirect ELISA on plates coated with calf thymus DNA (5 g/ml; Sigma-Aldrich, Taufkirchen, Germany) and AP-conjugated goat anti-mouse polyvalent immunoglobulins antibody (Sigma-Aldrich). Serum from MRL/lpr mice was used in 1:1250 to 1:10,000 dilution as positive control in autoantibody assays.
MC-21 antibody was used to stain Ccr2 on peripheral blood leukocytes (21) . Detection was performed with PE-conjugated polyclonal goat anti-rat IgG (P64; Biomeda, Foster City, CA). For simultaneous CD11b staining, a FITC-conjugated mAb (clone M1/70, BD Biosciences) was used.
Statistical Analyses
Data are shown as means Ϯ SD and were analyzed either by twotailed unpaired t test (parametric data), Mann-Whitney U test (nonparametric data), or log-rank test (survival). P Ͻ 0.05 was considered significant.
Results
Generation of Ccr2-Deficient MRL/lpr Mice
Ccr2-deficient mice were generated using the targeting strategy outlined in Figure 1 . They were viable, fertile, and indistinguishable from their wt littermates. Absence of Ccr2 protein on the cell surface of blood monocytes was demonstrated by flow cytometry ( Figure 1D ). Ccr2-deficient mice were backcrossed for seven generations onto the inbred strain MRL/lpr and then intercrossed to obtain Ccr2 Ϫ/Ϫ MRL/lpr mice. Because the contribution of the MRL/lpr genetic background in these mice exceeds 99%, wt MRL/lpr mice were used as controls. 
Body Weight, Splenomegaly, and Lymphadenopathy
The body, spleen, and right axillary lymph node weights of Ccr2 ϩ/ϩ and Ccr2 Ϫ/Ϫ MRL/lpr mice were determined at the age of 14 and 20 wk (Figure 2 ). There was no difference in body weight between wt and Ccr2 Ϫ/Ϫ MRL/lpr mice. In contrast, the spleen weights were significantly reduced in Ccr2 Ϫ/Ϫ MRL/lpr mice at 14 wk but not at 20 wk. Lymph node weights were significantly reduced in Ccr2 Ϫ/Ϫ MRL/lpr mice at 14 and 20 wk.
Time Course of Blood Urea Nitrogen and Albuminuria
No statistically significant differences in blood urea nitrogen (BUN) were observed between wt and Ccr2-deficient MRL/lpr mice at 8, 14, and 20 wk of age ( Figure 3 ). Urinary albumin excretion increased between weeks 8 and 20 in MRL/lpr wt mice with a marked interanimal variability and was significantly reduced in Ccr2-deficient MRL/lpr mice at 8 and 14 wk (Figure 3 ).
Histopathologic and Immunohistochemical Findings
At the age of 14 wk, Ccr2 ϩ/ϩ MRL/lpr mice showed enlarged hypercellular glomeruli, an increase in mesangial matrix, and a mild peritubular mononuclear cell infiltrate ( Figure  4A ). In addition, prominent perivascular lymphoid cell accumulations were present at this time point, which may be related to the lymphoproliferative process of these mice (16, 17) . At the age of 20 wk, Ccr2 ϩ/ϩ MRL/lpr mice showed locally and focally variable signs of intraglomerular necrosis, sclerosis, and crescent formation and peritubular mononuclear cell infiltration with increased overall tubular damage and focal tubular atrophy and intratubular protein cast formation ( Figure 4A ). In addition, mild signs of tubulointerstitial fibrosis could be observed. No vasculitis was detected. These lesions were significantly reduced in Ccr2 Ϫ/Ϫ MRL/lpr mice ( Figure 4 ).
Immune Complex Deposition
IgG and C3 depositions were analyzed by immunofluorescence within the glomeruli of 14-and 20-wk-old Ccr2 ϩ/ϩ and Ccr2 Ϫ/Ϫ MRL/lpr mice. No differences in immune complex and complement C3 depositions were observed between wt and Ccr2-deficient MRL/lpr mice ( Figure 5A ).
Kidney T Cell and Macrophage Infiltration
Infiltration of the kidney by T lymphocytes and macrophages was analyzed by immunohistochemical staining for CD3 and ER-HR3 ( Figure 5B ). At 14 and 20 wk of age, low numbers of T cells and macrophages were found in the glomerular compartment, which were significantly reduced in Ccr2-deficient MRL/ lpr mice at 20 wk of age ( Figure 5C ). The number of glomerular macrophages was also determined by Mac-2 staining, which detects a broader range of macrophage subpopulations than ER-HR3 staining (22) . As expected, the number of Mac-2 ϩ cells per glomerulus was an order of magnitude higher for both groups and reduced in Ccr2-deficient mice (week 20 13.4 Ϯ 4.7 versus 9.5 Ϯ 5.0; wt n ϭ 9, KO n ϭ 15; P ϭ 0.034 one-tailed unpaired t test, P ϭ 0.068 two-tailed test). In the tubulointerstitial compartment, both CD3 ϩ T cells and ER-HR3 ϩ macro- Figure 2 . Effect of Ccr2 deficiency on body weight, splenomegaly, and lymphadenopathy. The body weight, the spleen weight, and the weight of the right axillary lymph node were determined in 14-and 20-wk-old wt and Ccr2-deficient MRL/ lpr mice (body: week 14 wt n ϭ 20, knockout [KO] n ϭ 15; week 20 wt n ϭ 12, KO n ϭ 17; spleen: week 14 wt n ϭ 13, KO n ϭ 15, P ϭ 0.006; week 20 wt n ϭ 12, KO n ϭ 10; lymph node: week 14 wt n ϭ 17, KO n ϭ 15, P ϭ 0.031; week 20 wt n ϭ 12, KO n ϭ 10, P ϭ 0.016). Figure 3 . Effect of Ccr2 deficiency on blood urea nitrogen (BUN) and proteinuria. BUN levels were measured in serum samples from wt and Ccr2-deficient MRL/lpr mice (week 8 wt n ϭ 8, KO n ϭ 6; week 14 wt n ϭ 14, KO n ϭ 19; week 20 wt n ϭ 13, KO n ϭ 21). Albuminuria was determined by ELISA in urine samples from wt and Ccr2-deficient MRL/lpr mice (week 8 wt n ϭ 20, KO n ϭ 8, P ϭ 0.018; week 14 wt n ϭ 15, KO n ϭ 23, P ϭ 0.0014; week 20 wt n ϭ 14, KO n ϭ 19).
phages were significantly reduced in Ccr2-deficient MRL/lpr mice at both time points ( Figure 5 , B and C).
Intraglomerular Cell Proliferation
Intraglomerular cell proliferation was analyzed by immunohistochemical staining for Ki-67. A prominent signal was observed mainly in glomeruli of 14-wk-old Ccr2 ϩ/ϩ MRL/lpr mice, consistent with a more acute/proliferative phase of glomerulonephritis ( Figure 5B ). At 20 wk, fewer Ki-67-positive cells were detected within the glomeruli, and proliferative lesions were replaced by necrosis and sclerosis. Ccr2-deficient MRL/lpr mice had fewer Ki-67-positive cells per glomerulus, at both 14 and 20 wk of age as compared with age-matched Ccr2 ϩ/ϩ MRL/lpr mice ( Figure 5C ).
Expression of Proinflammatory Cytokines, Chemokines, and Chemokine Receptors
Multiprobe RPA was used to analyze mRNA expression of selected cytokines, chemokines, and chemokine receptors in kidneys of 14-and 20-wk-old Ccr2 ϩ/ϩ and Ccr2 Ϫ/Ϫ MRL/lpr No differences were observed between both groups (wt 16.2 Ϯ 7.8, n ϭ 6; KO 15.0 Ϯ 11.6, n ϭ 7; P ϭ 0.833).
Circulating Immunoglobulins
Circulating Ig isotype levels and anti-dsDNA antibodies were determined in 14-and 20-wk-old wt and Ccr2-deficient MRL/lpr mice ( Figure 9 ). We noticed a three-to four-fold decrease in IgG2a between weeks 14 and 20 in all mice. With the exception of anti-dsDNA antibodies ( Figure 9B ), no significant differences between wt and Ccr2-deficient MRL/lpr mice were observed ( Figure 9A ). 
Immunoscreen of Peripheral Blood
Survival Analysis
Ccr2 ϩ/ϩ MRL/lpr mice showed a median (50%) survival time of 25.7 Ϯ 2 wk (95% confidence interval 21.8 to 29.6), which was increased to 38.7 Ϯ 10.6 wk (95% confidence interval 18.0 to 59.4) in Ccr2 Ϫ/Ϫ MRL/lpr mice. The statistical analysis of the survival data revealed a significant prolongation of survival in Ccr2-deficient MRL/lpr mice ( Figure 11 ).
Discussion
The immune injury, a more uniform picture is emerging. Our results obtained with the model of systemic lupus in Ccr2-deficient MRL/lpr mice support a role for this receptor in the development of the systemic autoimmune parameters, as well as in the local leukocyte infiltrates, especially in the kidney, the major target organ in lupus. Consistent with a role of Ccr2 in the general immune response, Ccr2 Ϫ/Ϫ MRL/lpr mice developed less lymphadenopathy and had a lower percentage of CD4 ϩ and CD8 ϩ peripheral T lymphocytes ( Figure 10 ).
In keeping with an important role for Ccr2 in the infiltration of T cells and macrophages in the kidney, Ccr2-deficient MRL/ lpr mice showed reduced glomerular and tubulointerstitial CD3 ϩ T cell and ER-HR3 ϩ and Mac2 ϩ macrophage infiltrates and less glomerular cell proliferation, with a corresponding reduction in proteinuria and renal disease. This occurred despite unchanged hyperimmunoglobulinemia and comparable glomerular immune complex and complement deposits. There was, however, a reduction in plasma anti-dsDNA antibody titers at 20 wk of age. Finally, these changes were associated with a prolongation of overall survival of Ccr2 Ϫ/Ϫ MRL/lpr mice as compared with Ccr2 ϩ/ϩ MRL/lpr controls. These effects cannot be attributed to differences in genetic background between the Ccr2 ϩ/ϩ and Ccr2 Ϫ/Ϫ MRL/lpr mice, as the knockout strain had been backcrossed for seven generations and therefore represents an incipient congenic strain. Our results support roles for Ccr2 in the development of the autoimmune disease, especially the generation of activated T cells and anti-dsDNA antibody production, and in the development of renal injury, thereby influencing disease progression and survival of MRL/lpr mice. The phenotypes of Ccr2-deficient mice in diverse disease models have been summarized recently (15) . Depending on the model used, the disease parameters and the outcome in Ccr2 Ϫ/Ϫ mice were worse (24), unchanged (25), or improved (26) . With some Figure 9 . Effect of Ccr2 deficiency on circulating Ig isotype levels. (A) Serum from wt (week 14 n ϭ 7, week 20 n ϭ 6) and Ccr2-deficient MRL/lpr mice (week 14 n ϭ 8, week 20 n ϭ 7) was analyzed by ELISA for Ig isotype levels. (B) Serum from 20-wk-old wt (n ϭ 6) and Ccr2-deficient MRL/lpr mice (n ϭ 7) was analyzed by ELISA for anti-dsDNA antibodies (1:200 P ϭ 0.002, 1:400 P ϭ 0.008). Figure 10 . Effect of Ccr2 deficiency on leukocyte subsets in peripheral blood. Peripheral blood from wt (week 14 n ϭ 7, week 20 n ϭ 6) and Ccr2-deficient MRL/lpr mice (week 14 n ϭ 8, week 20 n ϭ 7) was analyzed by flow cytometry using antibodies directed against CD3, CD4, CD8, and B220. exceptions, autoimmune (27) (28) (29) and inflammatory disease models (30) were generally improved in Ccr2 Ϫ/Ϫ mice, whereas most infectious models had a more severe outcome (31, 32) . Overall, these diverse studies support a role for Ccr2 in leukocyte recruitment to the site of immune injury. A potential shift of the Th1-Th2 response in Ccr2 Ϫ/Ϫ mice has been discussed, but, depending on the model used, conflicting results have been obtained (11, (32) (33) (34) (35) . On the basis of the lack of difference in the Ig isotypes in Ccr2 Ϫ/Ϫ MRL/lpr mice compared with those in the Ccr2 ϩ/ϩ MRL/lpr mice, our data seem not to support a major shift in Th1-Th2 balance in this model. Furthermore, IFN-␥ mRNA levels were unchanged in spleens from wt and Ccr2-deficient mice at 20 wk. We did observe, however, decreased IFN-␥ mRNA levels in kidneys from Ccr2-deficient mice, which would indicate a defect in Th1 response, as previously reported for Ccr2 MRL/lpr mice and by Abdi et al. (44) in the spleens of mice that received transplants suggests a regulatory role of Ccr2 in the activation of CD8 ϩ T cells during the immune-mediated disease. A previous report from our group has shown that in peripheral blood of BALB/c mice with apoferritin-induced glomerulonephritis, only 4% of the CD4 ϩ and 3% of the CD8 ϩ T cells expressed Ccr2, but 63 and 30% of these cell types that were isolated from inflamed kidneys were positive for Ccr2 (21) . In the context of the MRL/lpr mouse, our finding of reduced peripheral CD8 ϩ T cells in Ccr2 Ϫ/Ϫ MRL/lpr mice potentially could point toward a contributory role of T cells in the development of nephritis (45, 46) . Despite the reduction in lymphadenopathy in either the Ccr2 Ϫ/Ϫ (these data) or the Ccl2 Ϫ/Ϫ MRL/lpr mice (5), the polyclonal hyperimmunoglobulinemia persisted in both models. Thus, the autoreactive B cell expansion of the MRL/lpr mouse seems to be independent of Ccr2 or its ligand. Consistent with the unchanged circulating antibody levels, the glomerular deposition of Ig and complement were unchanged by Ccr2 deficiency in the MRL/lpr mice. Together, these results add to the growing number of studies in MRL/lpr mice showing that local immune complex deposition and complement activation alone seem to be insufficient to induce a full-blown glomerular inflammatory response. This has been observed with elimination of the receptor for the Ig FcR (47); for the cytokines IFN-␥ (37), IL-12 (48), and CSF-1 (49); and for the chemokine Ccl2 (5, 8) or the respective receptors, e.g., Ifngr1 (50) or Ccr2 (this report). The mitigation of the immune-mediated renal disease may be a reason for the improved survival. As previously reported by others and us, glomerular chemokine production follows immune complex deposition and precedes the leukocyte infiltration, which in turn precedes the development of proteinuria (5, 6) . At with immune complex disease as previously reported by us (21) . Furthermore, the diminished T cell infiltration may not necessarily reflect a direct role for Ccr2 in T cell migration but could also be a consequence of the reduced macrophage infiltration leading to less secondary T cell recruitment (46) . The reduced Ccr1, Ccr3, and Ccr5 mRNA levels in kidneys of Ccr2 Ϫ/Ϫ MRL/lpr mice may simply reflect the decrease in number of infiltrating macrophages and T cells that express-in addition to Ccr2-Ccr1, Ccr3, or Ccr5 (21) . Taken together, the ligand-receptor pair Ccl2 and Ccr2 seems to play a significant role in glomerular and in tubulointerstitial macrophage and T cell infiltration in MRL/lpr lupus nephritis and contribute to its progression toward terminal renal insufficiency. Surprisingly, the reduced renal pathology of the Ccr2 Ϫ/Ϫ MRL/lpr mice at 20 wk of age was not consistently associated with a reduction in BUN levels or proteinuria. In contrast, the mild proteinuria at 14 wk of age was significantly reduced in Ccr2-deficient mice, but this did not persist as proteinuria progressed. The reasons for this discrepancy between the improved histopathology and the unchanged proteinuria remain unclear.
In conclusion, our results in Ccr2-deficient MRL/lpr mice suggest a role for this receptor in the development of lupus-like disease manifestations consisting of lymphoproliferation, activation of T cells, generation of anti-dsDNA antibodies, renal disease with chemokine and cytokine production, and mononuclear cell infiltration, resulting in proteinuria and progressive renal insufficiency. The reduction in the development of the lupus-like disease in the Ccr2 Ϫ/Ϫ MRL/lpr mice leads to prolongation of life, pointing toward a role for Ccr2 in the development and progression in immune complex-mediated renal disease.
